Recombinant Human IFNG/IFN-gamma Protein, N-His

Description of Recombinant Human IFNG/IFN-gamma Protein, N-His

Introduction

Recombinant human IFNG/IFN-gamma protein is a highly versatile and potent cytokine that plays a crucial role in the immune response against infections and cancer. This protein is produced by recombinant DNA technology, making it a valuable tool for research and therapeutic applications. In this article, we will discuss the structure, activity, and various applications of recombinant human IFNG/IFN-gamma protein.

Structure of Recombinant Human IFNG/IFN-gamma Protein

Recombinant human IFNG/IFN-gamma protein is a homodimeric protein consisting of two identical subunits, each with a molecular weight of approximately 16 kDa. The subunits are linked by disulfide bonds and are derived from a single polypeptide chain of 166 amino acids. The protein has a typical structure of cytokines, with a four-helix bundle and a long extended loop region.

Activity of Recombinant Human IFNG/IFN-gamma Protein

Recombinant human IFNG/IFN-gamma protein is a potent activator of immune cells, particularly T-cells and natural killer (NK) cells. It exerts its activity by binding to the IFN-gamma receptor, which is present on the surface of these cells. This binding initiates a signaling cascade that results in the activation of various immune cells, leading to the production of cytokines, chemokines, and other effector molecules. These molecules play a crucial role in the elimination of infected or cancerous cells.

Applications of Recombinant Human IFNG/IFN-gamma Protein

Research Applications

Recombinant human IFNG/IFN-gamma protein is widely used in research to study the immune response and its role in various diseases. It is used to stimulate immune cells in vitro and study their activation, proliferation, and cytokine production. This protein is also used to investigate the mechanisms of action of other cytokines and immune-modulating drugs.

Therapeutic Applications

Recombinant human IFNG/IFN-gamma protein has shown promising results in the treatment of several diseases, including chronic viral infections and cancer. It is used as an adjuvant therapy in combination with other drugs to enhance the immune response against viruses such as hepatitis B and C, and human papillomavirus (HPV). In cancer therapy, this protein is used to stimulate the immune system to recognize and attack cancer cells, leading to their destruction.

Diagnostic Applications

The ability of recombinant human IFNG/IFN-gamma protein to activate immune cells makes it a valuable tool for diagnostic purposes. It is used in various assays to detect the presence of specific antibodies or antigens, which can indicate the presence of certain diseases or infections. For example, IFNG/IFN-gamma release assays are used to diagnose tuberculosis and other mycobacterial infections.

Industrial Applications

Recombinant human IFNG/IFN-gamma protein is also used in the biotechnology industry for the production of other therapeutic proteins. It is used as a growth factor to enhance the production of monoclonal antibodies and other recombinant proteins in cell culture systems. This protein is also used in the development of biosimilars, which are biologic drugs that are highly similar to existing approved drugs.

Conclusion

In summary, recombinant human IFNG/IFN-gamma protein is a powerful cytokine with diverse applications in research, therapy, and diagnostics. Its unique structure and potent activity make it a valuable tool for studying the immune response and developing new treatments for diseases. With ongoing research and advancements in biotechnology, the potential applications of this protein are continuously expanding, making it an essential component in the field of immunology.